116 related articles for article (PubMed ID: 31956346)
1. Development and validation of a robust multigene signature as an aid to predict early relapse in stage I-III clear cell and papillary renal cell cancer.
Cao DL; Dai WX; Huang YQ; Yu LJ; Wu JL; Shi GH; Zhang HL; Zhu Y; Dai B; Ye DW
J Cancer; 2020; 11(5):997-1007. PubMed ID: 31956346
[No Abstract] [Full Text] [Related]
2. Construction and Validation of a 9-Gene Signature for Predicting Prognosis in Stage III Clear Cell Renal Cell Carcinoma.
Wu J; Jin S; Gu W; Wan F; Zhang H; Shi G; Qu Y; Ye D
Front Oncol; 2019; 9():152. PubMed ID: 30941304
[No Abstract] [Full Text] [Related]
3. Development and validation of a novel mRNA signature for predicting early relapse in non-small cell lung cancer.
Lin J; Weng J; Lin S; Lin C; Huang J; Zhang C; Zhang S; Dong C; Ji H; Ke X
Jpn J Clin Oncol; 2021 Aug; 51(8):1277-1286. PubMed ID: 34037221
[TBL] [Abstract][Full Text] [Related]
4. A robust gene signature for the prediction of early relapse in stage I-III colon cancer.
Dai W; Li Y; Mo S; Feng Y; Zhang L; Xu Y; Li Q; Cai G
Mol Oncol; 2018 Apr; 12(4):463-475. PubMed ID: 29377588
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
[TBL] [Abstract][Full Text] [Related]
6. Transcriptome profiling reveals an integrated mRNA-lncRNA signature with predictive value of early relapse in colon cancer.
Dai W; Feng Y; Mo S; Xiang W; Li Q; Wang R; Xu Y; Cai G
Carcinogenesis; 2018 Oct; 39(10):1235-1244. PubMed ID: 29982331
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of an Autophagy Score Signature for the Prediction of Post-operative Survival in Colorectal Cancer.
Zhou Z; Mo S; Dai W; Ying Z; Zhang L; Xiang W; Han L; Wang Z; Li Q; Wang R; Cai G
Front Oncol; 2019; 9():878. PubMed ID: 31552190
[No Abstract] [Full Text] [Related]
8. Prognostic and predictive value of an autophagy-related signature for early relapse in stages I-III colon cancer.
Mo S; Dai W; Xiang W; Li Y; Feng Y; Zhang L; Li Q; Cai G
Carcinogenesis; 2019 Jul; 40(7):861-870. PubMed ID: 30933267
[TBL] [Abstract][Full Text] [Related]
9. Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.
Du JX; Chen C; Luo YH; Cai JL; Cai CZ; Xu J; Ni XJ; Zhu W
Gene; 2020 Dec; 762():144974. PubMed ID: 32707305
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of a potent multi-mRNA signature for the prediction of early relapse in hepatocellular carcinoma.
Cai J; Tong Y; Huang L; Xia L; Guo H; Wu H; Kong X; Xia Q
Carcinogenesis; 2019 Jul; 40(7):840-852. PubMed ID: 31059567
[TBL] [Abstract][Full Text] [Related]
11. Identifying and Validating of an Autophagy-Related Gene Signature for the Prediction of Early Relapse in Breast Cancer.
Min Y; Feng Y; Luo H; Hu D; Wei X; He D; Yin G; Fan S
Front Endocrinol (Lausanne); 2022; 13():824362. PubMed ID: 35250881
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a 12-gene expression signature to predict colon cancer prognosis.
Sun D; Chen J; Liu L; Zhao G; Dong P; Wu B; Wang J; Dong L
PeerJ; 2018; 6():e4942. PubMed ID: 29915691
[TBL] [Abstract][Full Text] [Related]
13. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
[TBL] [Abstract][Full Text] [Related]
14. ITGA2B and ITGA8 are predictive of prognosis in clear cell renal cell carcinoma patients.
Lu X; Wan F; Zhang H; Shi G; Ye D
Tumour Biol; 2016 Jan; 37(1):253-62. PubMed ID: 26198048
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of a gene signature in clear cell renal cell carcinoma.
Chen L; Luo Y; Wang G; Qian K; Qian G; Wu CL; Dan HC; Wang X; Xiao Y
J Cell Physiol; 2019 Jul; 234(7):10324-10335. PubMed ID: 30417359
[TBL] [Abstract][Full Text] [Related]
16. Identification of a Glucose Metabolism-related Signature for prediction of Clinical Prognosis in Clear Cell Renal Cell Carcinoma.
Wang S; Zhang L; Yu Z; Chai K; Chen J
J Cancer; 2020; 11(17):4996-5006. PubMed ID: 32742447
[No Abstract] [Full Text] [Related]
17. Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients.
Yang H; Han M; Li H
Front Oncol; 2020; 10():707. PubMed ID: 32432045
[No Abstract] [Full Text] [Related]
18. A Combined four-mRNA Signature Associated with Lymphatic Metastasis for Prognosis of Colorectal Cancer.
Li X; Zhang Q; Zhao L; Jiang L; Qi A; Wei Q; Song X; Wang L; Zhang L; Zhao Y; Lv X; Wei M; Zhao L
J Cancer; 2020; 11(8):2139-2149. PubMed ID: 32127941
[No Abstract] [Full Text] [Related]
19. Prognostic values of a novel multi-mRNA signature for predicting relapse of cholangiocarcinoma.
Guo H; Cai J; Wang X; Wang B; Wang F; Li X; Qu X; Kong X; Gao Y; Wu H; Sun X; Xia Q; Kong X
Int J Biol Sci; 2020; 16(5):869-881. PubMed ID: 32071556
[TBL] [Abstract][Full Text] [Related]
20. A Robust 8-Gene Prognostic Signature for Early-Stage Non-small Cell Lung Cancer.
He R; Zuo S
Front Oncol; 2019; 9():693. PubMed ID: 31417870
[No Abstract] [Full Text] [Related]
[Next] [New Search]
